Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1535284rdf:typepubmed:Citationlld:pubmed
pubmed-article:1535284lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:1535284lifeskim:mentionsumls-concept:C0038856lld:lifeskim
pubmed-article:1535284lifeskim:mentionsumls-concept:C0021080lld:lifeskim
pubmed-article:1535284lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:1535284lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:1535284lifeskim:mentionsumls-concept:C0021079lld:lifeskim
pubmed-article:1535284lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:1535284lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:1535284lifeskim:mentionsumls-concept:C1519667lld:lifeskim
pubmed-article:1535284pubmed:issue1lld:pubmed
pubmed-article:1535284pubmed:dateCreated1992-7-28lld:pubmed
pubmed-article:1535284pubmed:abstractTextNormal bone marrow cells become immunosuppressive when cultured with supernatants of metastatic Lewis lung carcinoma (LLC-LN7) cells. The suppressor-inducing activities in the LLC-LN7 supernatants are interleukin-3 and granulocyte/macrophage-colony-stimulating factor. In the present study, the mechanisms by which these induced suppressor cells (LLCsup-BM) mediate their immunosuppression were investigated. The suppression by LLCsup-BM of splenic concanavalin CA blastogenesis was not dependent on cell contact since immunosuppression occurred regardless of whether the LLCsup-BM were separated from the responder spleen cells by a permeable membrane or if the LLCsup-BM were cocultured with the spleen cells. Culture supernatants of LLCsup-BM also inhibited T cell blastogenesis, being more suppressive than were supernatants of control bone marrow cells, which had been precultured with medium. The suppression by the soluble inhibitors elaborated from the LLCsup-BM was not restricted to the inhibition of T cell function as the supernatants also inhibited the natural killer activity of normal spleen cells. Studies to determine the identity of the suppressive activity produced by the LLCsup-BM showed increased levels of transforming growth factor beta (TGF beta) in their supernatants. Immunosuppressive bone marrow and spleen cells obtained from mice bearing metastatic LLC-LN7 tumors also secreted more TGF beta than did the cells obtained from normal mice. When anti-TGF beta antibodies were added to the LLCsup-BM supernatants, the suppressive activity was diminished. These results suggest that the LLCsup-BM mediate at least part of their immunosuppression through production of TGF beta.lld:pubmed
pubmed-article:1535284pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1535284pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1535284pubmed:languageenglld:pubmed
pubmed-article:1535284pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1535284pubmed:citationSubsetIMlld:pubmed
pubmed-article:1535284pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1535284pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1535284pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1535284pubmed:statusMEDLINElld:pubmed
pubmed-article:1535284pubmed:issn0340-7004lld:pubmed
pubmed-article:1535284pubmed:authorpubmed-author:YoungM RMRlld:pubmed
pubmed-article:1535284pubmed:authorpubmed-author:YoungM EMElld:pubmed
pubmed-article:1535284pubmed:authorpubmed-author:WrightM AMAlld:pubmed
pubmed-article:1535284pubmed:authorpubmed-author:CooganMMlld:pubmed
pubmed-article:1535284pubmed:authorpubmed-author:BagashJJlld:pubmed
pubmed-article:1535284pubmed:issnTypePrintlld:pubmed
pubmed-article:1535284pubmed:volume35lld:pubmed
pubmed-article:1535284pubmed:ownerNLMlld:pubmed
pubmed-article:1535284pubmed:authorsCompleteYlld:pubmed
pubmed-article:1535284pubmed:pagination14-8lld:pubmed
pubmed-article:1535284pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:meshHeadingpubmed-meshheading:1535284-...lld:pubmed
pubmed-article:1535284pubmed:year1992lld:pubmed
pubmed-article:1535284pubmed:articleTitleTumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta.lld:pubmed
pubmed-article:1535284pubmed:affiliationDepartment of Research Services, Hines V. A. Hospital, IL 60141.lld:pubmed
pubmed-article:1535284pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1535284pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1535284pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1535284lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1535284lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1535284lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1535284lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1535284lld:pubmed